Prof. Dr. Ahmet Özdoğan
Otology & Ear

Otoacoustic Emissions (OAE)

An objective test measuring the sound energy produced by outer hair cells; the first step of the 2-stage protocol used in newborn hearing screening and ototoxic drug monitoring.

From a otology and ear disease perspective, Otoacoustic Emissions (OAE) connects the patient's description with objective findings. An objective test measuring the sound energy produced by outer hair cells; the first step of the 2-stage protocol used in newborn hearing screening and ototoxic drug monitoring. Daily impact, safety signals and response to earlier care must be considered before the term becomes clinically useful. this topic assessment interprets hearing level, this term ear pressure, the finding discharge history, this entry dizziness pattern and the clinical point daily communication impact together. This dictionary entry is patient education that keeps final decisions tied to examination and current reports. The first clinical frame for the dictionary entry is to separate functional impact from safety concerns: OAE measures the sound energy emitted backwards from the cochlea after outer hair cells are stimulated by sound. This distinction prevents rushed treatment decisions.

Evaluation of this topic is less about naming the complaint and more about separating risk from functional effect. this term infection clues, the dictionary entry trauma history, allergy-reflux pattern, smoking exposure, occupational load and previous surgery can change the pathway. this topic review may gather otoscopy, this term microscopic examination, the finding audiometry-tympanometry and this entry temporal bone imaging inside the the clinical point file. the dictionary entry interpretation separates hearing type, this topic eardrum mobility, this term ossicular chain status, the finding vestibular findings and this topic prior infection history. Assessment of this term looks for consistency between history and examination: A 2-stage protocol is followed in newborn hearing screening: OAE screening in the birth hospital, confirmation with ABR within 1 month in infants who do not pass. If findings do not match, staged reassessment or a second opinion may be clearer than moving directly to a procedure. Tests are meaningful only when they add real value to the clinical plan.

Planning for the finding compares expected benefit, procedural burden and follow-up needs in the same frame. If patient goals and objective findings do not match, the this entry decision is revisited. the clinical point planning discusses medication or drops, the dictionary entry hearing aids, this topic vestibular rehabilitation, this term tympanoplasty-stapes surgery or the finding implant options by finding. The goal in this entry is not to choose the most aggressive option, but to find the right step between safe observation and effective intervention. The selected pathway should fit safe monitoring and realistic outcome expectations.

this term follow-up rereads the original goal, current complaint and examination finding in one file. the finding follow-up tracks hearing change, this entry ear discharge, the clinical point dizziness, the dictionary entry tinnitus burden and this topic quality-of-life impact together. When this term is explained, patient goals, medical necessity and realistic expectations meet on the same ground. Review timing changes when the the finding risk profile falls or rises.

Preparation for this entry records the most disturbing symptom, pace of change, daily-life effect and prior treatments separately; these notes make diagnostic questions easier to see.

When comparing reports daily-life impact preserves personal decision boundaries; For terminology clarity, otoacoustic assessment, emissions review, otoacoustic report language, emissions definition, otoacoustic history, emissions assessment clarify the patient question.

Interpreting OAE Testing

The presence of an OAE response in a frequency band indicates the integrity of outer hair cells in that band; absence points to at least 30 dBHL loss or middle ear pathology. Absence of OAE alone is not diagnostic; it must be interpreted together with tympanometry and audiometry.

In DPOAE, a DP-gram is generated at the 2f1-f2 frequency; a decline of 6 dB or more between 0.5-4 kHz is considered significant. In the presence of SSCD (superior semicircular canal dehiscence), high amplitude DPOAE can be observed without an air-bone gap. High-frequency DPOAE (4-8 kHz) is particularly valuable in detecting early noise damage and ototoxicity.

Clinical Applications of OAE

In newborn screening programmes, OAE is preferred as a physiological test because it is fast, painless and feasible; however, it is not sufficient alone and is supported by ABR. Baseline OAE and serial measurements should be standard protocol in patients receiving ototoxic drugs.

In the assessment of functional (non-organic) hearing loss, OAE is compared with pure-tone audiometry; if a normal OAE threshold is inconsistent with reported high audiometric thresholds, simulation should be considered. Evaluating OAE findings together with tympanometry is useful in differentiating Menière's and SSCD.

OAE Reliability

OAE is a reliable, reproducible test that requires no cooperation; these properties make it valuable in paediatric and special-needs populations. Ambient noise and vernix or cerumen in the external auditory canal can affect results; it is therefore recommended to perform it in a quiet environment.

OAE does not give reliable results in the presence of middle ear pathology; effusion, perforation or negative pressure can invalidate the test. OAE may be normal in cochlear nerve lesions — it must therefore be used together with ABR in the diagnosis of auditory neuropathy spectrum disorder.

When Should OAE Be Done?

In newborns it should be performed within the first 48 hours after birth as part of the standard screening protocol. Confirmation with ABR within 1 month is mandatory in infants who do not pass screening. Baseline OAE before treatment should be obtained in every patient receiving ototoxic drugs.

Serial OAE measurements in individuals working in noisy occupational environments are helpful in early detection of changes from baseline. OAE should be requested as part of the audiological evaluation package at the onset of sudden sound change or tinnitus.

Frequently asked questions

What is Otoacoustic Emissions (OAE)?
An objective test measuring the sound energy produced by outer hair cells; the first step of the 2-stage protocol used in newborn hearing screening and ototoxic drug monitoring. From a otology and ear disease perspective, Otoacoustic Emissions (OAE) connects the patient's description with objective findings.
When is Otoacoustic Emissions (OAE) clinically important?
Evaluation of this topic is less about naming the complaint and more about separating risk from functional effect. It is considered with audiological and ENT assessment when ear pain, hearing loss, tinnitus, dizziness or ear fullness is present.
When is ENT assessment relevant for Otoacoustic Emissions (OAE)?
ENT assessment becomes relevant if symptoms last more than a few weeks, become one-sided or progressive, or are accompanied by breathing, swallowing, voice, hearing or neck-mass findings.
What information helps assessment of Otoacoustic Emissions (OAE)?
It is useful to note when symptoms started, which side is affected, previous operations or treatments, current medication, imaging and test reports, and the effect on daily life. It is considered with audiological and ENT assessment when ear pain, hearing loss, tinnitus, dizziness or ear fullness is present.

Learn more about this procedure

Detailed guide from Prof. Dr. Özdoğan's clinic

View Guide →

References

This glossary entry is for informational purposes only and does not constitute medical advice. Consult a qualified specialist for diagnosis and treatment.

Back to Medical Dictionary
Message on WhatsAppCall